JPS5520717A - Saccharide-transfusing agent - Google Patents

Saccharide-transfusing agent

Info

Publication number
JPS5520717A
JPS5520717A JP9343578A JP9343578A JPS5520717A JP S5520717 A JPS5520717 A JP S5520717A JP 9343578 A JP9343578 A JP 9343578A JP 9343578 A JP9343578 A JP 9343578A JP S5520717 A JPS5520717 A JP S5520717A
Authority
JP
Japan
Prior art keywords
maltose
xylitol
saccharide
concentration
urine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP9343578A
Other languages
Japanese (ja)
Inventor
Tadashi Ukigaya
Mitsuo Ozeki
Tsunero Oda
Satoru Kubomura
Yoshio Hashimoto
Akira Murayama
Kazuko Yamaura
Katsuo Wakao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NIKKEN KAGAKU KK
Kowa Co Ltd
Original Assignee
NIKKEN KAGAKU KK
Nikken Chemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NIKKEN KAGAKU KK, Nikken Chemicals Co Ltd filed Critical NIKKEN KAGAKU KK
Priority to JP9343578A priority Critical patent/JPS5520717A/en
Publication of JPS5520717A publication Critical patent/JPS5520717A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

PURPOSE: A saccharide-transfusing agent obtained by the addition of xylitol in maltose in a specific ratio, which remarkably reduces the maltose evacuation into urine.
CONSTITUTION: Maltose and xylitol are blended in a weight ratio of 7:3W9:1. The concentration of saccharides is preferably adjusted in order to make the solution isotonic to blood. For example, when the ratio of maltose to xylitol is 7:3, the concentration is preferably ca. 7.7% (w/v); when 8:2, ca. 8.35% (w/v); and when 9:1, ca. 9.55% (w/v). The solution is preferably in the range of pH 6.0W7.5. Maltose can be transfused twice in concentration as glucose. The loss of maltose into urine, which is a disadvantage of maltose, can be suppressed by the blend of xylitol.
COPYRIGHT: (C)1980,JPO&Japio
JP9343578A 1978-07-31 1978-07-31 Saccharide-transfusing agent Pending JPS5520717A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9343578A JPS5520717A (en) 1978-07-31 1978-07-31 Saccharide-transfusing agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9343578A JPS5520717A (en) 1978-07-31 1978-07-31 Saccharide-transfusing agent

Publications (1)

Publication Number Publication Date
JPS5520717A true JPS5520717A (en) 1980-02-14

Family

ID=14082223

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9343578A Pending JPS5520717A (en) 1978-07-31 1978-07-31 Saccharide-transfusing agent

Country Status (1)

Country Link
JP (1) JPS5520717A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816445A (en) * 1984-06-21 1989-03-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Crystalline alpha-maltose

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816445A (en) * 1984-06-21 1989-03-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Crystalline alpha-maltose

Similar Documents

Publication Publication Date Title
JPS53113008A (en) Constant rate releasing preparation
AU669122B2 (en) New pyrazine derivatives, their preparation and their use
JPS56169598A (en) Measuring composition
JPS5639782A (en) Stabilization of thrombin
EP0367271A3 (en) Improved red blood cell preservative solution
JPS53148518A (en) Stabilized prostaglandin e composition and its preparation
JPS574922A (en) Agent for lowering ammonia in blood
JPS5315321A (en) O-ethyl-s-#-propyl-o-2,2,2-trihardethyl-phosphorothiolate or thionothiolate, their preparation and insecticides, miticides and menatocides containing same as active constituents
JPS57130545A (en) Urea adsorbing agent
JPS5791912A (en) Concentrated electrolyte solution for intravenous nutrition transfusion
JPS56160991A (en) Stabilized dihydrofolate reductase
JPS5233662A (en) Preparation of n2-naphthalenesulfonyl-alginamides and acid addition sa lts thereof
JPS5630911A (en) Glucide transfusion agent
JPS53124682A (en) Preparation of complex of enzyme and bioactive substance and its use
JPS5398926A (en) Preparation of azodicarbonamides
JPS5630910A (en) Glucide transfusion agent
JPS5312866A (en) Preparation of 3-oxy-4h-pyran-4-one derivatives
JPS5742620A (en) Novel antiulcer agent
JPS5623891A (en) Stabilization of urokinaze by heating
JPS57106698A (en) Easily absorbable map composition and preparation containing the same
JPS5344591A (en) Preparation of adenine derivatives
JPS5426333A (en) Preparation of pesticide or disinfectant
JPS5721315A (en) Stable solid preparation of cytochrome c and its preparation
JPS5427571A (en) Preparation of piperidine derivatives
JPS5293778A (en) Preparation of n#-(2#-tetrahydrofuranyl)-5-fluorouracil